SHENZHEN – Contract manufacturer Jabil Circuit said it would invest $10 million in an injection molding facility here for the medical market.

The operation will begin with 18 injection presses, with plans for 50 within two years, according to published reports.

The Shenzhen plant will make drug delivery devices for the US and Europe, with the capacity to produce 12.5 million disposable devices per year. Jabil sees opportunities in the Chinese market down the line, the firm says.

The facility will be certified as a Class 8 clean room.

The company expects $300 million to $500 million in annual revenue from medical and life science devices by 2014.

• Prev
• Next